Marsha Treadwell, PhD

Title(s)Professor, Pediatrics
SchoolSchool of Medicine
Address35 Medical Center Way
San Francisco CA 94143
PronounsShe/Her/Hers
ORCID ORCID Icon0000-0003-0521-1846 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    Sanius Health2024  - 2025Top 80 Most Influential People and Advocates in Sickle Cell Disease: International Leader
    Cayenne Wellness Center2023Sickle Cell Disease Giants, Pioneers and Visionaries - Behavioral Health
    Allen Temple Health and Social Services Ministry2019Martin Luther King, Jr. Community Service Award
    Jordan Family Fund2019  - 2025Endowed Chair
    Sickle Cell Disease Association of America2017National Pioneer/Trailblazer Award
    Sickle Cell Disease Foundation2007Lifetime Achievement Award

    Collapse Overview 
    Collapse Overview
    I am a Professor In Residence in the Department of Pediatrics, Division of Hematology in the UCSF School of Medicine. I am Co-Director of the UCSF Sickle Cell Center of Excellence, an internationally recognized lifespan center. As a health services researcher and clinical psychologist, I have led multi-institutional, national and international, interdisciplinary teams conducting research on how social drivers, psychological and behavioral factors, and organizational structures and processes impact the health and well-being of individuals living with sickle cell disease (SCD) and their families. I am mPI on the Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) project funded by the National Heart, Lung and Blood Institute that aims to find adults with SCD unaffiliated from SCD specialty care and bring them into care. I am mPI and Regional Director for the Pacific Sickle Cell Regional Collaborative, a 13-state U.S. consortium funded by the Health Resources and Services Administration, that seeks to improve access to knowledgeable care for individuals with SCD of all ages. I am leading the Community Impact Strategic Planning for the UCSF Benioff Children’s Hospitals that has the charter to harness, amplify and grow health equity focused efforts that will have transformational impact on childhood community health equity. I am a licensed clinical psychologist and my research and clinical work has focused on improving quality of life, quality of care, patient reported outcomes and transition from pediatric to adult care for individuals living with SCD and their families. I received my doctorate in clinical child psychology from the University of Washington in Seattle, Washington, and Advanced Training in Clinical Research from UCSF.

    Collapse Research 
    Collapse Research Activities and Funding
    "REAL Answers" (Registry Expansion Analyses to Learn)
    National Heart, Lung and Blood Institute 1U01HL167036-01Aug 20, 2023 - Jul 31, 2028
    Role: Site PI
    Description: REAL Answers prospectively compares the effect of new SCD medications – crizanlizumab, voxelotor, and L-glutamine – on clinical outcomes in individuals with SCD; identify genetic and genomic predictors of response to crizanlizumab, voxelotor, and L-glutamine; and integrate study data into the CureSCi metadata catalog (MDC) to enhance future cross-study analyses.
    Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
    National Heart, Lung and Blood Institute 1R01 HL158807 01Apr 1, 2022 - Mar 31, 2027
    Role: mPI
    Description: The goal of RECIPE (Recruitment and Engagement in Care to Impact Practice Enhancement) for Sickle Cell Disease is to find patients unaffiliated from sickle cell disease specialty care using three distinct pathways (community, hospital-based and surveillance); engage them in care using linkage coordinators (a successful method adapted from HIV care), and assess the contextual factors and implementation support needed to ensure these methodologies can be further scaled up at a national level.
    Pacific Sickle Cell Regional Collaborative
    Health Resources and Services Administration, Sickle Cell Disease Treatment Demonstration Program 5 U1EMC27862 08 00Sep 1, 2021 - Aug 31, 2026
    Role: mPI and Regional Director
    Description: Goals: 1) Strengthen systems of care for individuals with sickle cell disease (SCD) and their families by synergizing with the SCD Newborn Screening Follow-Up Program, the SCDTDP regions, and the Hemoglobinopathies National Coordinating Center to facilitate partnerships between clinicians, community organizations and other stakeholders; 2) Improve outcomes for individuals with SCD and their families by developing and strengthening regional and state SCD network infrastructures that includes components necessary for providing comprehensive SCD services; and 3) Develop and support comprehensive care teams in seven states to increase access to evidence based care and the latest treatment options, increase collaboration and care coordination and implement telehealth technologies. Foundational to these goals is the establishment and maintenance of reporting mechanisms to provide data annually, by state and for the Pacific Sickle Cell Regional Collaborative (PSCRC), on achievement of goals and objectives of the program.
    SC-Links - Linking the Sickle Cell Community, Providers and Systems to Improve Sickle Cell Disease Care
    NIH U01HL134007Aug 5, 2016 - Jun 30, 2022
    Role: Co-Principal Investigator
    STIMULUS - Science & Technology Immersion for Underrepresented Learners in the U.S.
    NIH R25HL125451Apr 1, 2015 - Mar 31, 2025
    Role: Co-Principal Investigator
    Psychobiological Reactivity in Sickle Cell Disease
    NIH K23HL076660Aug 1, 2005 - Jul 31, 2011
    Role: Principal Investigator

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Improving Completion Rates of Transcranial Doppler Ultrasounds in Children With Sickle Cell Disease Using Quality Improvement Efforts: In-Clinic Versus Population-Based Assessments. Pediatr Blood Cancer. 2025 Apr; 72(4):e31549. Vissa M, Parikh P, McCulloch C, Bhasin N, Cabana MD, Chung J, Marsh A, Wong T, Treadwell M, Bardach NS. PMID: 39833618.
      View in: PubMed   Mentions:    Fields:    
    2. Genomics and Health Data Governance in Africa: Democratize the Use of Big Data and Popularize Public Engagement. Hastings Cent Rep. 2024 Dec; 54 Suppl 2:S84-S92. Munung NS, Royal CD, de Kock C, Awandare G, Nembaware V, Nguefack S, Treadwell M, Wonkam A. PMID: 39707935.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Challenges of Engaging Primary Care Providers in Specialized Telementoring Education About Sickle Cell Disease for Sickle Cell Specialists: Results from the Sickle Cell Disease Training and Mentoring Program for Primary Care Providers (STAMP) Project ECHO. AJPM Focus. 2025 Feb; 4(1):100304. Shook LM, House B, Farrell CB, Stewart R, Lanzkron S, King AA, Varughese T, Strouse JJ, Treadwell M, Kanter J. PMID: 39866157; PMCID: PMC11758125.
      View in: PubMed   Mentions:
    4. Depression, sleep and pain affect instrumental activities of daily living through cognitive functioning in adults with sickle cell disease: A report from the Sickle Cell Disease Implementation Consortium. Br J Haematol. 2025 Mar; 206(3):944-953. Longoria JN, Howell KE, Porter JS, Treadwell M, King AA, Gordeuk V, Shah N, Abrams CM, McCuskee S, Gollan S, Hankins JS, Heitzer AM, Sickle Cell Disease Implementation Consortium. PMID: 39564946.
      View in: PubMed   Mentions:    Fields:    
    5. Association of Surgical Splenectomy and Venous Thromboembolism and Stroke in People with Sickle Cell Disease. Blood. 2024 Nov 5; 144(Supplement 1):5308. Lee LB, Betensky BM, Boucher BA, Cohen CA, Cronin CR, Desai DP, Gopal GS, Guarino GS, Hsu HL, Idowu IM, Kanter KJ, Lanzkron LS, Little LJ, Mandernach MM, Manwani MD, McNaull MM, Rehman RS, Rivlin RK, Sayani SF, Strouse SJ, Treadwell TM, Wong WT, Naik NR. .
      View in: Publisher Site   Mentions:
    6. Reproductive Health Surveys Administered in Sickle Cell Clinics Can Inform Personalized Care and Multidisciplinary Collaboration. Blood. 2024 Nov 5; 144(Supplement 1):2239-2239. Rush RG, E Mohamed ER, Moffatt-Bazile MK, Jamalpur JS, Guzzardo GG, Sathi SB, Jacob JS, Van Doren VL, Velez VM, Ogu OU, Smink SG, Schultz SC, Gomez GE, Yap YB, Lopez LE, Quarmyne QM, Light LJ, Vichinsky VE, Hagar HR, Treadwell TM, Strouse SJ, Bhasin BN. .
      View in: Publisher Site   Mentions:
    7. Tracking Telehealth Needs for Individuals With Sickle Cell Disease Through the COVID-19 Pandemic: A Cross-Sectional Survey Study. Health Sci Rep. 2024 Nov; 7(11):e70163. Treadwell M, Du L, Lawrence Y, Gaspar M, Hassell K, Shah S, Akpan M, Crook N, Taylor M, Gopal S, Pacific Sickle Cell Regional Collaborative. PMID: 39507678; PMCID: PMC11538030.
      View in: PubMed   Mentions:
    8. Patient-reported pregnancy loss and maternal complications: Insights from the sickle cell disease implementation consortium. Int J Gynaecol Obstet. 2025 Mar; 168(3):1131-1142. Mathias JG, Masese RV, King AA, Bulgin D, Stevenson E, Hankins JS, Glassberg JA, Kanter J, Preiss L, Treadwell M, Knisely MR, Tanabe PJ, Gibson R, Gordeuk VR, Shah NR. PMID: 39450678; PMCID: PMC11825282.
      View in: PubMed   Mentions:    Fields:    
    9. Impact of an individualized pain plan to treat sickle cell disease vaso-occlusive episodes in the emergency department. Blood Adv. 2024 10 22; 8(20):5330-5338. Siewny L, King A, Melvin CL, Carpenter CR, Hankins JS, Colla JS, Preiss L, Luo L, Cox L, Treadwell M, Davila N, Masese RV, McCuskee S, Gollan SS, Tanabe P. PMID: 38815230; PMCID: PMC11568751.
      View in: PubMed   Mentions:    Fields:    Translation:CTClinical Trials
    10. Burden of employment loss and absenteeism in adults and caregivers of children with sickle cell disease. Blood Adv. 2024 03 12; 8(5):1143-1150. Gordon RD, Welkie RL, Quaye N, Hankins JS, Kassim AA, Thompson AA, Treadwell M, Lin CJ, Cronin RM. PMID: 38231083; PMCID: PMC10909714.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Mortality in adults with sickle cell disease: Results from the sickle cell disease implementation consortium (SCDIC) registry. Am J Hematol. 2024 05; 99(5):900-909. Njoku F, Pugh N, Brambilla D, Kroner B, Shah N, Treadwell M, Gibson R, Hsu LL, Gordeuk VR, Glassberg J, Hankins JS, Kutlar A, King AA, Kanter J. PMID: 38450756; PMCID: PMC11001513.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Social determinants of health and treatment center affiliation: analysis from the sickle cell disease implementation consortium registry. BMC Health Serv Res. 2024 Mar 06; 24(1):291. Mendez GG, Nocek JM, Brambilla DJ, Jacobs S, Cole O, Kanter J, Glassberg J, Saving KL, Melvin CL, Gibson RW, Treadwell M, Jackson GL, King AA, Gordeuk VR, Kroner B, Hsu LL, Sickle Cell Disease Implementation Consortium. PMID: 38448911; PMCID: PMC10916176.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Stepping Systematically Forward Toward Health Equity in Sickle Cell Disease. JAMA Pediatr. 2024 Mar 01; 178(3):225. Marsh AM, Treadwell MJ. PMID: 38190149.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Perceptions and preferences for genetic testing for sickle cell disease or trait: a qualitative study in Cameroon, Ghana and Tanzania. Eur J Hum Genet. 2024 Oct; 32(10):1307-1313. Munung NS, Kamga KK, Treadwell MJ, Dennis-Antwi J, Anie KA, Bukini D, Makani J, Wonkam A. PMID: 38374470; PMCID: PMC11499917.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    15. The effect of an adapted digital mental health intervention for sickle cell disease on engagement: a pilot randomized controlled trial. BMC Digital Health. 2023 Dec 18; 1(1):54. Nardo NE, Parchuri PE, O’Brien OJ, Crosby CL, Porter PJ, Palermo PT, Nikolajski NC, Treadwell TM, Hillery HC, Szigethy SE, Jonassaint JC. .
      View in: Publisher Site   Mentions:
    16. Optimizing Acute Sickle Cell Care at Community Health Partners Medical Center. Blood. 2023 Nov 28; 142(Supplement 1):7234. Means MJ, Palmer PN, Uller UJ, Park PD, Hwang HA, Chinnock CB, Treadwell TM, Macmillan MP, Abdulhaq AH, Viau VW, Ravi RN, Bukari BS. .
      View in: Publisher Site   Mentions:
    17. Role of Menstrual Bleeding Assessments in Sickle Cell Clinics in Improving Quality of Care for Women- a Multicenter Approach. Blood. 2023 Nov 28; 142(Supplement 1):665. Bhasin BN, Rush RG, Strouse SJ, Moffatt-Bazile MK, Mohamed MR, Jacob JS, Sathi SB, Smink SG, Schultz SC, DiVirgilio DN, Vichinsky VE, Velez VM, Hagar HR, Quarmyne QM, Ogu OU, Treadwell TM. .
      View in: Publisher Site   Mentions:
    18. Grndad and Disease Modifying Therapy (DMT): Shifts in Dmt Are Seen at the Adolescent/Young Adult Transition in Sickle Cell Disease in a Multi-Site Prospective Registry. Blood. 2023 Nov 28; 142(Supplement 1):798. Lanzkron LS, Manwani MD, Kanter KJ, Sinha SA, Miller MR, Cronin CR, Jacob JS, Harper HJ, Anderson AA, Treadwell TM, Owusu-Ansah OA, Fuh FB, Mandernach MM, Gollamudi GJ, Saccente SS, Lilla LS, McNaull MM, LeBlanc LD, Saving SK, Guarino GS, Betensky BM, Cohen CA, Raj RA, Sayani SF, Shah SS, Narang NS, Sathi SB, Strouse SJ, Wong WT, Alvarez AO, Gopal GS, Liang LJ, Semakula SD, Chang CM, Rivlin RK, Rehman RS, Shook SL, Frei-Jones FM, Little LJ. .
      View in: Publisher Site   Mentions:
    19. Impact of an Individualized Pain Plan (IPP) for Adults with Sickle Cell Disease Experiencing a Vaso-Occlusive Episode (VOE) on Patient Satisfaction and ED Provider Confidence in Treating Pain. Blood. 2023 Nov 28; 142(Supplement 1):3671. Masese MR, Siewny SL, Gollan GS, Glassberg GJ, Gordeuk GV, Hankins HJ, Melvin MC, Preiss PL, Tanabe TP, Treadwell TM, King KA. .
      View in: Publisher Site   Mentions:
    20. Looking ahead: ethical and social challenges of somatic gene therapy for sickle cell disease in Africa. Gene Ther. 2024 05; 31(5-6):202-208. Munung NS, Nnodu OE, Moru PO, Kalu AA, Impouma B, Treadwell MJ, Wonkam A. PMID: 38012299; PMCID: PMC11090833.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    21. "The project did not come to us with a solution": Perspectives of research teams on implementing a study about electronic health record-embedded individualized pain plans for emergency department treatment of vaso-occlusive episodes in adults with sickle cell disease. BMC Health Serv Res. 2023 Nov 13; 23(1):1245. Baumann AA, Hankins JS, Hsu LL, Gibson RW, Richardson LD, Treadwell M, Glassberg JA, Bourne S, Luo L, Masese RV, Demartino T, Nocek J, Taaffe E, Gollan S, Ruiz OO, Nwosu C, Qashou N, James AS, Tanabe P, King AA. PMID: 37953236; PMCID: PMC10641983.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Caught between pity, explicit bias, and discrimination: a qualitative study on the impact of stigma on the quality of life of persons living with sickle cell disease in three African countries. Qual Life Res. 2024 Feb; 33(2):423-432. Munung NS, Treadwell M, Kamga KK, Dennis-Antwi J, Anie K, Bukini D, Makani J, Wonkam A. PMID: 37889387; PMCID: PMC10850006.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    23. Burden of Aging: Health Outcomes Among Adolescents and Young Adults With Sickle Cell Disease. Hemasphere. 2023 Aug; 7(8):e930. Howell KE, Pugh N, Longoria J, Shah N, Kutlar A, Gordeuk VR, King AA, Glassberg J, Kayle M, Melvin C, Treadwell M, Hankins JS, Porter JS. PMID: 37456969; PMCID: PMC10348722.
      View in: PubMed   Mentions: 1  
    24. Mental health and psychological resilience in sickle cell disease. Lancet Haematol. 2023 08; 10(8):e569-e571. Treadwell MJ. PMID: 37451306.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. The Effect of an Adapted Digital Mental Health Intervention for Sickle Cell Disease on Engagement: A Pilot Randomized Controlled Trial. Res Sq. 2023 Jun 28. Parchuri E, Nardo E, O'Brien J, Crosby L, Porter J, Palermo T, Nikolajski CE, Treadwell M, Hillery C, Szigethy E, Jonassaint C. PMID: 37461733; PMCID: PMC10350243.
      View in: PubMed   Mentions:
    26. Examining Mental Health, Education, Employment, and Pain in Sickle Cell Disease. JAMA Netw Open. 2023 05 01; 6(5):e2314070. Harris KM, Preiss L, Varughese T, Bauer A, Calhoun CL, Treadwell M, Masese R, Hankins JS, Hussain FA, Glassberg J, Melvin CL, Gibson R, King AA, Sickle Cell Disease Implementation Consortium. PMID: 37200033; PMCID: PMC10196879.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    27. CureSCi Metadata Catalog-Making sickle cell studies findable. PLoS One. 2022; 17(12):e0256248. Pan H, Ives C, Mandal M, Qin Y, Hendershot T, Popovic J, Brambilla D, Stratford J, Treadwell M, Wu X, Kroner B. PMID: 36508412; PMCID: PMC9744304.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    28. Assent, parental consent and reconsent for health research in Africa: thematic analysis of national guidelines and lessons from the SickleInAfrica registry. BMC Med Ethics. 2022 12 08; 23(1):130. Munung NS, Nembaware V, Osei-Tutu L, Treadwell M, Chide OE, Bukini D, Tutuba H, SickleInAfrica ELSI WG, Wonkam A. PMID: 36482457; PMCID: PMC9730625.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    29. Quality of Life in Sickle Cell Disease: What Matters. Hematol Oncol Clin North Am. 2022 12; 36(6):1137-1149. Treadwell MJ, Anie KA. PMID: 36400535.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    30. Baseline Patient and Provider Reports of Quality of Care and Confidence Providing ED Management of Vaso-Occlusive Episodes. Blood. 2022 Nov 15; 140(Supplement 1):2570-2571. Tanabe TP, Hankins HJ, Gibson GR, Gordeuk GV, Melvin MC, Preiss PL, Siewny SL, Richardson RL, Treadwell TM, King KA. .
      View in: Publisher Site   Mentions:
    31. A New Phen X Collection: Sickle Cell Disease Psychosocial and Social Determinants of Health Protocols. Blood. 2022 Nov 15; 140(Supplement 1):7898-7899. Crosby CL, King KA, Porter PJ, Badawy BS, Bulgin BD, Hardy HS, Arnold AS, Williford WD, Treadwell TM, Huggins HW, Ives IC, Sullivan SM, Hamilton HC. .
      View in: Publisher Site   Mentions:
    32. Mortality in Adults with Sickle Cell Disease: Results from the Sickle Cell Disease Implementation Consortium (SCDIC) Registry. Blood. 2022 Nov 15; 140(Supplement 1):2586-2588. Njoku NF, Pugh PN, Treadwell TM, Glassberg GJ, Kutlar KA, Gibson GR, Shah SN, Gordeuk GV, Hsu HL, Hankins HJ, King KA, Kanter KJ. .
      View in: Publisher Site   Mentions:
    33. Optimizing Shared Decision Making about Hydroxyurea in Young Children with Sickle Cell Anemia. Blood. 2022 Nov 15; 140(Supplement 1):10857-10859. Hildenbrand HA, King KA, Mara MC, Johnson JY, Shook SL, Whitacre WC, Britto BM, Quinn QC, Brinkman BW, Hackworth HR, Raphael RJ, Tubman TV, Thompson TA, Smith-Whitley SK, Badawy BS, Creary CS, Bhasin BN, Treadwell TM, Reader RS, Rampersad RA, Sobota SA, Crosby CL. .
      View in: Publisher Site   Mentions:
    34. What does it mean to be affiliated with care?: Delphi consensus on the definition of "unaffiliation" and "specialist" in sickle cell disease. PLoS One. 2022; 17(11):e0272204. Lamont AE, Hsu LL, Jacobs S, Gibson R, Treadwell M, Chen Y, Lottenberg R, Axelrod K, Varughese T, Melvin C, Smith S, Chukwudozie IB, Kanter J, Sickle Cell Disease Implementation Consortium. PMID: 36367870; PMCID: PMC9651581.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    35. Barriers to hydroxyurea use from the perspectives of providers, individuals with sickle cell disease, and families: Report from a U.S. regional collaborative. Front Genet. 2022; 13:921432. Treadwell MJ, Du L, Bhasin N, Marsh AM, Wun T, Bender MA, Wong TE, Crook N, Chung JH, Norman S, Camilo N, Cavazos J, Nugent D. PMID: 36092883; PMCID: PMC9461276.
      View in: PubMed   Mentions: 11  
    36. Transitioning Adolescents With Sickle Cell Disease From Pediatric to Adult Care: Results From a New Survey of Health Care Professionals. J Pediatr Hematol Oncol. 2022 10 01; 44(7):e999-e1005. Shah NR, Treadwell MJ, Vichinsky E. PMID: 35700397.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    37. An evaluation of patient-reported outcomes in sickle cell disease within a conceptual model. Qual Life Res. 2022 Sep; 31(9):2681-2694. Treadwell MJ, Mushiana S, Badawy SM, Preiss L, King AA, Kroner B, Chen Y, Glassberg J, Gordeuk V, Shah N, Snyder A, Wun T, Sickle Cell Disease Implementation Consortium (SCDIC). PMID: 35445915; PMCID: PMC9356962.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    38. Perspectives of individuals with sickle cell disease on barriers to care. PLoS One. 2022; 17(3):e0265342. Phillips S, Chen Y, Masese R, Noisette L, Jordan K, Jacobs S, Hsu LL, Melvin CL, Treadwell M, Shah N, Tanabe P, Kanter J. PMID: 35320302; PMCID: PMC8942270.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    39. Pregnancy outcomes with hydroxyurea use in women with sickle cell disease. Am J Hematol. 2022 05; 97(5):603-612. Kroner BL, Hankins JS, Pugh N, Kutlar A, King AA, Shah NR, Kanter J, Glassberg J, Treadwell M, Gordeuk VR, Sickle Cell Disease Implementation Consortium. PMID: 35142007; PMCID: PMC8986611.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    40. Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA. BMJ Open. 2021 11 17; 11(11):e050880. Smeltzer MP, Howell KE, Treadwell M, Preiss L, King AA, Glassberg JA, Tanabe P, Badawy SM, DiMartino L, Gibson R, Kanter J, Klesges LM, Hankins JS, Sickle Cell Disease Implementation Consortium. PMID: 34789492; PMCID: PMC8601067.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    41. Early Evaluation of the Use of Crizanlizumab in Sickle Cell Disease: A National Alliance of Sickle Cell Centers Study. Blood. 2021 Nov 5; 138(Supplement 1):3113-3113. Kanter KJ, Hellemann HG, Cohen CA, Manwani MD, Idowu IM, Guarino GS, Saif Ur Rehman SS, Treadwell TM, Clay CE, Owusu-Ansah OA, Little LJ, Desai DP, Madisetti MM, Lanzkron LS. .
      View in: Publisher Site   Mentions:
    42. Improving Completion Rates of Transcranial Doppler Ultrasounds in Children with Sickle Cell Disease Using Quality Improvement Efforts: In-Clinic Vs. Population-Based Assessments. Blood. 2021 Nov 5; 138(Supplement 1):1886-1886. Vissa VM, Treadwell TM, Bardach BN. .
      View in: Publisher Site   Mentions:
    43. Sex-based differences in the manifestations and complications of sickle cell disease: Report from the Sickle Cell Disease Implementation Consortium. PLoS One. 2021; 16(10):e0258638. Masese RV, Bulgin D, Knisely MR, Preiss L, Stevenson E, Hankins JS, Treadwell MJ, King AA, Gordeuk VR, Kanter J, Gibson R, Glassberg JA, Tanabe P, Shah N, Sickle Cell Disease Implementation Consortium. PMID: 34714833; PMCID: PMC8555833.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    44. Patient-reported neurocognitive symptoms influence instrumental activities of daily living in sickle cell disease. Am J Hematol. 2021 11 01; 96(11):1396-1406. Longoria JN, Pugh NL, Gordeuk V, Hsu LL, Treadwell M, King AA, Gibson R, Kayle M, Crego N, Glassberg J, Melvin CL, Hankins JS, Porter J. PMID: 34350622; PMCID: PMC8855994.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    45. Engaging Caregivers and Providers of Children With Sickle Cell Anemia in Shared Decision Making for Hydroxyurea: Protocol for a Multicenter Randomized Controlled Trial. JMIR Res Protoc. 2021 May 21; 10(5):e27650. Hood AM, Strong H, Nwankwo C, Johnson Y, Peugh J, Mara CA, Shook LM, Brinkman WB, Real FJ, Klein MD, Hackworth R, Badawy SM, Thompson AA, Raphael JL, Yates AM, Smith-Whitley K, King AA, Calhoun C, Creary SE, Piccone CM, Hildenbrand AK, Reader SK, Neumayr L, Meier ER, Sobota AE, Rana S, Britto M, Saving KL, Treadwell M, Quinn CT, Ware RE, Crosby LE. PMID: 34018965; PMCID: PMC8178738.
      View in: PubMed   Mentions: 6  
    46. Electronic Health Record-Embedded Individualized Pain Plans for Emergency Department Treatment of Vaso-occlusive Episodes in Adults With Sickle Cell Disease: Protocol for a Preimplementation and Postimplementation Study. JMIR Res Protoc. 2021 Apr 16; 10(4):e24818. Luo L, King AA, Carroll Y, Baumann AA, Brambilla D, Carpenter CR, Colla J, Gibson RW, Gollan S, Hall G, Klesges L, Kutlar A, Lyon M, Melvin CL, Norell S, Mueller M, Potter MB, Richesson R, Richardson LD, Ryan G, Siewny L, Treadwell M, Zun L, Armstrong-Brown J, Cox L, Tanabe P. PMID: 33861209; PMCID: PMC8087964.
      View in: PubMed   Mentions: 3  
    47. Improving Preventive Care for Children With Sickle Cell Anemia: A Quality Improvement Initiative. Pediatr Qual Saf. 2021 Jan-Feb; 6(1):e379. Cabana MD, Marsh A, Treadwell MJ, Stemmler P, Rowland M, Bender MA, Bhasin N, Chung JH, Hassell K, Abdul Rashid NFN, Wong TE, Bardach NS. PMID: 33409431; PMCID: PMC7781296.
      View in: PubMed   Mentions: 2  
    48. Association between hospital admissions and healthcare provider communication for individuals with sickle cell disease. Hematology. 2020 Dec; 25(1):229-240. Cronin RM, Yang M, Hankins JS, Byrd J, Pernell BM, Kassim A, Adams-Graves P, Thompson AA, Kalinyak K, DeBaun M, Treadwell M. PMID: 32552526; PMCID: PMC7440685.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    49. Predictors of Maternal Morbidity Among Participants Enrolled in the Sickle Cell Disease Implementation Consortium Registry. Blood. 2020 Nov 5; 136(Supplement 1):3-3. Masese MR, Bulgin BD, Preiss PL, Knisely KM, Stevenson SE, Hankins HJ, Treadwell TM, King KA, Gordeuk GV, Kanter KJ, Gibson GR, Glassberg GJ, Tanabe TP, Shah SN. .
      View in: Publisher Site   Mentions:
    50. Hydroxyurea Use and Outcomes of Pregnancy in Sickle Cell Disease. Blood. 2020 Nov 5; 136(Supplement 1):33-33. Gordeuk GV, Kroner KB, Pugh PN, Hankins HJ, Kutlar KA, King KA, Shah SN, Kanter KJ, Glassberg GJ, Treadwell TM. .
      View in: Publisher Site   Mentions:
    51. Sex Based Differences in Sickle Cell Disease. Blood. 2020 Nov 5; 136(Supplement 1):37-37. Masese MR, Bulgin BD, Knisely KM, Preiss PL, Stevenson SE, Hankins HJ, Treadwell TM, King KA, Gordeuk GV, Kanter KJ, Gibson GR, Glassberg GJ, Tanabe TP, Shah SN. .
      View in: Publisher Site   Mentions:
    52. Intentional and unintentional nonadherence to hydroxyurea among people with sickle cell disease: a qualitative study. Blood Adv. 2020 09 22; 4(18):4463-4473. Hodges JR, Phillips SM, Norell S, Nwosu C, Khan H, Luo L, Badawy SM, King A, Tanabe P, Treadwell M, Rojas Smith L, Calhoun C, Hankins JS, Porter J. PMID: 32941646; PMCID: PMC7509876.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    53. Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects. Blood Adv. 2020 08 25; 4(16):3804-3813. Kanter J, Smith WR, Desai PC, Treadwell M, Andemariam B, Little J, Nugent D, Claster S, Manwani DG, Baker J, Strouse JJ, Osunkwo I, Stewart RW, King A, Shook LM, Roberts JD, Lanzkron S. PMID: 32785684; PMCID: PMC7448595.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    54. Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation Study. JMIR Res Protoc. 2020 Jul 14; 9(7):e16319. Hankins JS, Shah N, DiMartino L, Brambilla D, Fernandez ME, Gibson RW, Gordeuk VR, Lottenberg R, Kutlar A, Melvin C, Simon J, Wun T, Treadwell M, Calhoun C, Baumann A, Potter MB, Klesges L, Bosworth H, Sickle Cell Disease Implementation Consortium. PMID: 32442144; PMCID: PMC7388044.
      View in: PubMed   Mentions: 12  
    55. A National Measurement Framework to Assess and Improve Sickle Cell Care in 4 US Regions. Public Health Rep. 2020 Jul/Aug; 135(4):442-451. Faro EZ, Shook L, Treadwell MJ, King AA, Whiteman LN, Ivy ED, Hulihan M, Kavanagh PL, Selk S, Oyeku S, Berns SD. PMID: 32639897; PMCID: PMC7383758.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    56. Patient-reported outcomes in sickle cell disease and association with clinical and psychosocial factors: Report from the sickle cell disease implementation consortium. Am J Hematol. 2020 09; 95(9):1066-1074. Knisely MR, Pugh N, Kroner B, Masese R, Gordeuk V, King AA, Smith SM, Gurney JG, Adams R, Wun T, Snyder A, Glassberg J, Shah N, Treadwell M, Sickle Cell Disease Implementation Consortium. PMID: 32449965; PMCID: PMC8141351.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    57. Perceptions of US Adolescents and Adults With Sickle Cell Disease on Their Quality of Care. JAMA Netw Open. 2020 05 01; 3(5):e206016. Kanter J, Gibson R, Lawrence RH, Smeltzer MP, Pugh NL, Glassberg J, Masese RV, King AA, Calhoun C, Hankins JS, Treadwell M. PMID: 32469413; PMCID: PMC7260622.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    58. Paediatric to adult transition care for patients with sickle cell disease: a global perspective. Lancet Haematol. 2020 Apr; 7(4):e329-e341. Inusa BPD, Stewart CE, Mathurin-Charles S, Porter J, Hsu LL, Atoyebi W, De Montalembert M, Diaku-Akinwumi I, Akinola NO, Andemariam B, Abboud MR, Treadwell M. PMID: 32220342.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    59. Impact of Medicaid expansion on access and healthcare among individuals with sickle cell disease. Pediatr Blood Cancer. 2020 05; 67(5):e28152. Kayle M, Valle J, Paulukonis S, Holl JL, Tanabe P, French DD, Garg R, Liem RI, Badawy SM, Treadwell MJ. PMID: 32147964; PMCID: PMC7096276.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    60. Understanding sickle cell disease: impact of surveillance and gaps in knowledge. Blood Adv. 2020 02 11; 4(3):496-498. Kaur M, Brown M, Love TW, Thompson A, Treadwell M, Smith-Whitley K. PMID: 32027743; PMCID: PMC7013264.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    61. Chapter 8 Pediatric sickle cell disease. . 2020 Jan 1; 185-206. Kidwell KK, Treadwell TM, Crosby CL. .
      View in: Publisher Site   Mentions:
    62. Social and Psychological Factors Associated With Health Care Transition for Young Adults Living With Sickle Cell Disease. J Transcult Nurs. 2021 01; 32(1):21-29. Clayton-Jones D, Matthie N, Treadwell M, Field JJ, Mager A, Sawdy R, George Dalmida S, Leonard C, Koch KL, Haglund K. PMID: 31889479.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    63. Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study. Hematology. 2019 Dec; 24(1):189-198. Cronin RM, Hankins JS, Byrd J, Pernell BM, Kassim A, Adams-Graves P, Thompson A, Kalinyak K, DeBaun M, Treadwell M. PMID: 30479187; PMCID: PMC6349225.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    64. A Pilot Adult Sickle Cell Hematology Clinic in California's Inland Empire Improves Patient Outcome. Blood. 2019 Nov 13; 134(Supplement_1):3470-3470. Chiruvolu CN, Patel PA, Rowley RC, Treadwell TM, Vichinsky VE, Pakbaz PZ. .
      View in: Publisher Site   Mentions:
    65. Establishing a Multi-Country Sickle Cell Disease Registry in Africa: Ethical Considerations. Front Genet. 2019; 10:943. Munung NS, Nembaware V, de Vries J, Bukini D, Tluway F, Treadwell M, Sangeda RZ, Mazandu G, Jonas M, Paintsil V, Nnodu OE, Balandya E, Makani J, Wonkam A. PMID: 31649726; PMCID: PMC6795756.
      View in: PubMed   Mentions: 9  
    66. Exploring the Role of Shared Decision Making in the Consent Process for Pediatric Genomics Research in Cameroon, Tanzania, and Ghana. AJOB Empir Bioeth. 2019 Jul-Sep; 10(3):182-189. Bukini D, deVries J, Treadwell M, Anie K, Dennis-Antwi J, Kamga KK, McCurdy S, Ohene-Frempong K, Makani J, Wonkam A. PMID: 31379268; PMCID: PMC7255821.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    67. A STRATEGY FOR THE MEASUREMENT OF SICKLE CELL DISEASE SYMPTOMS FROM THE PATIENT PERSPECTIVE. HemaSphere. 2019 Jun 1; 3:320. Ojo OF, Litcher-Kelly LL, Mazar MI, Klooster KB, Roeder RA, Chaston CE, Ollis OS, Treadwell TM, Reasner RD. .
      View in: Publisher Site   Mentions:
    68. Barriers to Pediatric Sickle Cell Disease Guideline Recommendations. Glob Pediatr Health. 2019; 6:2333794X19847026. Cabana MD, Kanter J, Marsh AM, Treadwell MJ, Rowland M, Stemmler P, Bardach NS. PMID: 31106244; PMCID: PMC6501475.
      View in: PubMed   Mentions: 19  
    69. Lessons Learned from Building a Pediatric-to-Adult Sickle Cell Transition Program. South Med J. 2019 03; 112(3):190-197. Smith WR, Sisler IY, Johnson S, Lipato TJ, Newlin JS, Owens ZS, Morgan AM, Treadwell MJ, Polak K. PMID: 30830235; PMCID: PMC6590675.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    70. Development of a Hydroxyurea Decision Aid for Parents of Children With Sickle Cell Anemia. J Pediatr Hematol Oncol. 2019 01; 41(1):56-63. Crosby LE, Walton A, Shook LM, Ware RE, Treadwell M, Saving KL, Britto M, Peugh J, McTate E, Oyeku S, Nwankwo C, Brinkman WB. PMID: 30044352; PMCID: PMC7359001.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    71. Measurement of Sickle Cell Disease Symptoms from the Patient Perspective: Considerations for Clinical Trials. Blood. 2018 Nov 29; 132(Supplement 1):3571-3571. Ojo OF, Litcher-Kelly LL, Mazar MI, Klooster KB, Ollis OS, Chaston CE, Roeder RA, Treadwell TM, Reasner RD. .
      View in: Publisher Site   Mentions:
    72. Pediatric residents' perceived barriers to opioid use in sickle cell disease pain management. Pediatr Blood Cancer. 2019 02; 66(2):e27535. Fearon A, Marsh A, Kim J, Treadwell M. PMID: 30387290; PMCID: PMC6301127.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    73. Virtual reality as complementary pain therapy in hospitalized patients with sickle cell disease. Pediatr Blood Cancer. 2019 02; 66(2):e27525. Agrawal AK, Robertson S, Litwin L, Tringale E, Treadwell M, Hoppe C, Marsh A. PMID: 30362236.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    74. The sickle cell disease implementation consortium: Translating evidence-based guidelines into practice for sickle cell disease. Am J Hematol. 2018 12; 93(12):E391-E395. DiMartino LD, Baumann AA, Hsu LL, Kanter J, Gordeuk VR, Glassberg J, Treadwell MJ, Melvin CL, Telfair J, Klesges LM, King A, Wun T, Shah N, Gibson RW, Hankins JS, Sickle Cell Disease Implementation Consortium. PMID: 30203558; PMCID: PMC6503654.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    75. Relation Between Religious Perspectives and Views on Sickle Cell Disease Research and Associated Public Health Interventions in Ghana. J Genet Couns. 2018 Sep 01. Dennis-Antwi JA, Ohene-Frempong K, Anie KA, Dzikunu H, Agyare VA, Boadu RO, Antwi JS, Asafo MK, Anim-Boamah O, Asubonteng AK, Agyei S, Wonkam A, Treadwell MJ. PMID: 30171429; PMCID: PMC6395545.
      View in: PubMed   Mentions: 10     Fields:    
    76. Modifying factors of the health belief model associated with missed clinic appointments among individuals with sickle cell disease. Hematology. 2018 Oct; 23(9):683-691. Cronin RM, Hankins JS, Byrd J, Pernell BM, Kassim A, Adams-Graves P, Thompson AA, Kalinyak K, DeBaun MR, Treadwell M. PMID: 29595096.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    77. Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠. Health Qual Life Outcomes. 2017 Jun 02; 15(1):117. Keller S, Yang M, Treadwell MJ, Hassell KL. PMID: 28577358; PMCID: PMC5455105.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    78. Stakeholder Perspectives on Public Health Genomics Applications for Sickle Cell Disease: A Methodology for a Human Heredity and Health in Africa (H3Africa) Qualitative Research Study. OMICS A Journal of Integrative Biology. 2017 Jun 1; 21(6):323-332. Treadwell TM, Makani MJ, Ohene-Frempong OK, Ofori-Acquah OS, McCurdy MS, de Vries dJ, Bukini BD, Dennis-Antwi DJ, Kamga KK, Mbekenga MC, Wonkam WE, Tangwa TG, Royal RC, Wonkam WA, as members of the H3Africa Consorti a. .
      View in: Publisher Site   Mentions:
    79. Impact of Elosulfase Alfa on Pain in Patients with Morquio A Syndrome over 52 Weeks. Journal of Inborn Errors of Metabolism and Screening. 2017 Jan 1; 5:2326409817718850. Treadwell TM, Harmatz HP, Burton BB, Mitchell MJ, Muschol MN, Jones JS, Pastores PG, Lau LH, Sparkes SR, Sutton SV, Meesen MB, Haller HC, Shaywitz SA, Gold GJ. .
      View in: Publisher Site   Mentions:
    80. Long-Term Pulmonary Function and Quality of Life in Children After Acute Respiratory Distress Syndrome: A Feasibility Investigation. Pediatr Crit Care Med. 2017 01; 18(1):e48-e55. Ward SL, Turpin A, Spicer AC, Treadwell MJ, Church GD, Flori HR. PMID: 28060170; PMCID: PMC5221949.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    81. Emergency department utilization by Californians with sickle cell disease, 2005-2014. Pediatr Blood Cancer. 2017 06; 64(6). Paulukonis ST, Feuchtbaum LB, Coates TD, Neumayr LD, Treadwell MJ, Vichinsky EP, Hulihan MM. PMID: 28000344; PMCID: PMC5403550.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    82. Mortality Among Women with Sickle Cell Disease Admitted for Delivery, California 2004-2014. Blood. 2016 Dec 2; 128(22):2332-2332. Raider RF, Paulukonis PS, Hagar HW, Treadwell TM, Hulihan HM. .
      View in: Publisher Site   Mentions:
    83. Self-efficacy and readiness for transition from pediatric to adult care in sickle cell disease. Int J Adolesc Med Health. 2016 Nov 01; 28(4):381-388. Treadwell M, Johnson S, Sisler I, Bitsko M, Gildengorin G, Medina R, Barreda F, Major K, Telfair J, Smith WR. PMID: 26226116.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    84. Impact of elosulfase alfa in patients with morquio A syndrome who have limited ambulation: An open-label, phase 2 study. Am J Med Genet A. 2017 Feb; 173(2):375-383. Harmatz PR, Mengel E, Geberhiwot T, Muschol N, Hendriksz CJ, Burton BK, Jameson E, Berger KI, Jester A, Treadwell M, Sisic Z, Decker C. PMID: 27774754; PMCID: PMC5298029.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    85. 278 Emergency Department Utilization by Californians With Sickle Cell Disease, 2005-2014. Annals of Emergency Medicine. 2016 Oct 1; 68(4):s108. Paulukonis PS, Vichinsky VE, Neumayr NL, Treadwell TM, Coates CT, Feuchtbaum FL, Hulihan HM. .
      View in: Publisher Site   Mentions:
    86. Barriers and facilitators to research participation among adults, and parents of children with sickle cell disease: A trans-regional survey. Am J Hematol. 2016 10; 91(10):E461-2. Cronin RM, Hankins JS, Adams-Graves P, Thompson AA, Kalinyak K, Byrd J, McClain B, Kassim A, DeBaun M, Treadwell M. PMID: 27421796.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    87. Quality of care in sickle cell disease: Cross-sectional study and development of a measure for adults reporting on ambulatory and emergency department care. Medicine (Baltimore). 2016 Aug; 95(35):e4528. Evensen CT, Treadwell MJ, Keller S, Levine R, Hassell KL, Werner EM, Smith WR. PMID: 27583862; PMCID: PMC5008546.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    88. Development of a sickle cell disease readiness for transition assessment. Int J Adolesc Med Health. 2016 May 01; 28(2):193-201. Treadwell M, Johnson S, Sisler I, Bitsko M, Gildengorin G, Medina R, Barreda F, Major K, Telfair J, Smith WR. PMID: 26226115.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    89. Community engagement to inform the development of a sickle cell counselor training and certification program in Ghana. J Community Genet. 2016 Jul; 7(3):195-202. Anie KA, Treadwell MJ, Grant AM, Dennis-Antwi JA, Asafo MK, Lamptey ME, Ojodu J, Yusuf C, Otaigbe A, Ohene-Frempong K. PMID: 27090687; PMCID: PMC4960026.
      View in: PubMed   Mentions: 10  
    90. Proceedings of a Sickle Cell Disease Ontology workshop - Towards the first comprehensive ontology for Sickle Cell Disease. Appl Transl Genom. 2016 Jun; 9:23-9. Mulder N, Nembaware V, Adekile A, Anie KA, Inusa B, Brown B, Campbell A, Chinenere F, Chunda-Liyoka C, Derebail VK, Geard A, Ghedira K, Hamilton CM, Hanchard NA, Haendel M, Huggins W, Ibrahim M, Jupp S, Kamga KK, Knight-Madden J, Lopez-Sall P, Mbiyavanga M, Munube D, Nirenberg D, Nnodu O, Ofori-Acquah SF, Ohene-Frempong K, Opap KB, Panji S, Park M, Pule G, Royal C, Sangeda R, Tayo B, Treadwell M, Tshilolo L, Wonkam A. PMID: 27354937; PMCID: PMC4911424.
      View in: PubMed   Mentions: 13  
    91. Global Challenges in Transition Care: One Program Models a Path for Young Adults with Sickle Cell Disease. Pediatrics. 2016 Feb 1; 137(Supplement 3):386a-386a. Marino MJ, Treadwell TM, Major MK. .
      View in: Publisher Site   Mentions:
    92. Impact of elosulfase alfa in patients with Morquio syndrome type A who have limited ambulation: An open-label, phase 2 study. Molecular Genetics and Metabolism. 2016 Feb 1; 117(2):s55. Harmatz HP, Jester JA, Mengel ME, Treadwell TM, Burton BB, Berger BK, Hendriksz HC, Geberhiwot GT, Sisic SZ, Decker DC. .
      View in: Publisher Site   Mentions:
    93. Teaching About Genetics and Sickle Cell Disease In Fifth Grade. J Natl Med Assoc. 2015 Feb; 107(1):4-10. Day LL, Murray E, Treadwell MJ, Lubin BH. PMID: 27282522.
      View in: PubMed   Mentions: 1     Fields:    
    94. Safety and physiological effects of two different doses of elosulfase alfa in patients with morquio a syndrome: A randomized, double-blind, pilot study. Am J Med Genet A. 2015 Oct; 167A(10):2272-81. Burton BK, Berger KI, Lewis GD, Tarnopolsky M, Treadwell M, Mitchell JJ, Muschol N, Jones SA, Sutton VR, Pastores GM, Lau H, Sparkes R, Genter F, Shaywitz AJ, Harmatz P. PMID: 26069231; PMCID: PMC4744659.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    95. Sickle cell disease and H3Africa: enhancing genomic research on cardiovascular diseases in African patients. Cardiovasc J Afr. 2015 Mar-Apr; 26(2 Suppl 1):S50-5. Wonkam A, Makani J, Ofori-Aquah S, Nnodu OE, Treadwell M, Royal C, Ohene-Frempong K, Members of the H3Africa Consortium. PMID: 25962948; PMCID: PMC4547555.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    96. Impact of elosulfase alfa on pain in patients with Morquio syndrome type A. Molecular Genetics and Metabolism. 2015 Feb 1; 114(2):s51-s52. Harmatz HP, Treadwell TM, Burton BB, Mitchell MJ, Muschol MN, Jones JS, Pastores PG, Lau LH, Sparkes SR, Sutton SV, Genter GF, Haller HC, Shaywitz SA. .
      View in: Publisher Site   Mentions:
    97. Adult sickle cell quality-of-life measurement information system (ASCQ-Me): conceptual model based on review of the literature and formative research. Clin J Pain. 2014 Oct; 30(10):902-14. Treadwell MJ, Hassell K, Levine R, Keller S. PMID: 24300219; PMCID: PMC4993284.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    98. Using formative research to develop a counselor training program for newborn screening in Ghana. J Genet Couns. 2015 Apr; 24(2):267-77. Treadwell MJ, Anie KA, Grant AM, Ofori-Acquah SF, Ohene-Frempong K. PMID: 25193810; PMCID: PMC4501216.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    99. Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH). Pediatr Blood Cancer. 2014 Dec; 61(12):2271-6. Paulukonis ST, Harris WT, Coates TD, Neumayr L, Treadwell M, Vichinsky E, Feuchtbaum LB. PMID: 25176145.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansPHPublic Health
    100. Patient reports of health outcome for adults living with sickle cell disease: development and testing of the ASCQ-Me item banks. Health Qual Life Outcomes. 2014 Aug 22; 12:125. Keller SD, Yang M, Treadwell MJ, Werner EM, Hassell KL. PMID: 25146160; PMCID: PMC4243820.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCTClinical Trials
    101. Research capacity. Enabling the genomic revolution in Africa. Science. 2014 Jun 20; 344(6190):1346-8. H3Africa Consortium, Rotimi C, Abayomi A, Abimiku A, Adabayeri VM, Adebamowo C, Adebiyi E, Ademola AD, Adeyemo A, Adu D, Affolabi D, Agongo G, Ajayi S, Akarolo-Anthony S, Akinyemi R, Akpalu A, Alberts M, Alonso Betancourt O, Alzohairy AM, Ameni G, Amodu O, Anabwani G, Andersen K, Arogundade F, Arulogun O, Asogun D, Bakare R, Balde N, Baniecki ML, Beiswanger C, Benkahla A, Bethke L, Boehnke M, Boima V, Brandful J, Brooks AI, Brosius FC, Brown C, Bucheton B, Burke DT, Burnett BG, Carrington-Lawrence S, Carstens N, Chisi J, Christoffels A, Cooper R, Cordell H, Crowther N, Croxton T, de Vries J, Derr L, Donkor P, Doumbia S, Duncanson A, Ekem I, El Sayed A, Engel ME, Enyaru JC, Everett D, Fadlelmola FM, Fakunle E, Fischbeck KH, Fischer A, Folarin O, Gamieldien J, Garry RF, Gaseitsiwe S, Gbadegesin R, Ghansah A, Giovanni M, Goesbeck P, Gomez-Olive FX, Grant DS, Grewal R, Guyer M, Hanchard NA, Happi CT, Hazelhurst S, Hennig BJ, Hertz- C, Hide W, Hilderbrandt F, Hugo-Hamman C, Ibrahim ME, James R, Jaufeerally-Fakim Y, Jenkins C, Jentsch U, Jiang PP, Joloba M, Jongeneel V, Joubert F, Kader M, Kahn K, Kaleebu P, Kapiga SH, Kassim SK, Kasvosve I, Kayondo J, Keavney B, Kekitiinwa A, Khan SH, Kimmel P, King MC, Kleta R, Koffi M, Kopp J, Kretzler M, Kumuthini J, Kyobe S, Kyobutungi C, Lackland DT, Lacourciere KA, Landouré G, Lawlor R, Lehner T, Lesosky M, Levitt N, Littler K, Lombard Z, Loring JF, Lyantagaye S, Macleod A, Madden EB, Mahomva CR, Makani J, Mamven M, Marape M, Mardon G, Marshall P, Martin DP, Masiga D, Mason R, Mate-Kole M, Matovu E, Mayige M, Mayosi BM, Mbanya JC, McCurdy SA, McCarthy MI, McIlleron H, Mc'Ligeyo SO, Merle C, Mocumbi AO, Mondo C, Moran JV, Motala A, Moxey-Mims M, Mpoloka WS, Msefula CL, Mthiyane T, Mulder N, Mulugeta Gh, Mumba D, Musuku J, Nagdee M, Nash O, Ndiaye D, Nguyen AQ, Nicol M, Nkomazana O, Norris S, Nsangi B, Nyarko A, Nyirenda M, Obe E, Obiakor R, Oduro A, Ofori-Acquah SF, Ogah O, Ogendo S, Ohene-Frempong K, Ojo A, Olanrewaju T, Oli J, Osafo C, Ouwe Missi Oukem-Boyer O, Ovbiagele B, Owen A, Owolabi MO, Owolabi L, Owusu-Dabo E, Pare G, Parekh R, Patterton HG, Penno MB, Peterson J, Pieper R, Plange-Rhule J, Pollak M, Puzak J, Ramesar RS, Ramsay M, Rasooly R, Reddy S, Sabeti PC, Sagoe K, Salako T, Samassékou O, Sandhu MS, Sankoh O, Sarfo FS, Sarr M, Shaboodien G, Sidibe I, Simo G, Simuunza M, Smeeth L, Sobngwi E, Soodyall H, Sorgho H, Sow Bah O, Srinivasan S, Stein DJ, Susser ES, Swanepoel C, Tangwa G, Tareila A, Tastan Bishop O, Tayo B, Tiffin N, Tinto H, Tobin E, Tollman SM, Traoré M, Treadwell MJ, Troyer J, Tsimako-Johnstone M, Tukei V, Ulasi I, Ulenga N, van Rooyen B, Wachinou AP, Waddy SP, Wade A, Wayengera M, Whitworth J, Wideroff L, Winkler CA, Winnicki S, Wonkam A, Yewondwos M, sen T, Yozwiak N, Zar H. PMID: 24948725; PMCID: PMC4138491.
      View in: PubMed   Mentions: 238     Fields:    Translation:Humans
    102. A Quality Improvement Initiative to Improve Emergency Department Care for Pediatric Patients with Sickle Cell Disease. J Clin Outcomes Manag. 2014 Feb; 21(2):62-70. Treadwell MJ, Bell M, Leibovich SA, Barreda F, Marsh A, Gildengorin G, Morris CR. PMID: 26412961; PMCID: PMC4580258.
      View in: PubMed   Mentions: 1     Fields:    
    103. Quality Improvement Goals for Sickle Cell Disease Pain Management in an Urban Pediatric Emergency Department: We Can Do Better!. Blood. 2012 Nov 16; 120(21):2101-2101. Morris MC, Barreda BF, Leibovich LS, Rutherford RM, Saulys SA, Stewart SM, Lavrisha LL, Vichinsky VE, Bell BM, Treadwell TM. .
      View in: Publisher Site   Mentions:
    104. A biopsychosocial-spiritual model of chronic pain in adults with sickle cell disease. Pain Manag Nurs. 2013 Dec; 14(4):287-301. Taylor LEV, Stotts NA, Humphreys J, Treadwell MJ, Miaskowski C. PMID: 24315252; PMCID: PMC3857562.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    105. Screening U.S. college athletes for their sickle cell disease carrier status. Am J Prev Med. 2011 Dec; 41(6 Suppl 4):S406-12. Jordan LB, Smith-Whitley K, Treadwell MJ, Telfair J, Grant AM, Ohene-Frempong K. PMID: 22099365.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    106. Mental Health Symptoms, Quality of Life and Barriers to Accessing Health Care in Sickle Cell Disease. Blood. 2011 Nov 18; 118(21):337-337. Treadwell TM, Barreda BF, Major MK, Walker WV, Payton PW, Kaur KK, Vichinsky VE. .
      View in: Publisher Site   Mentions:
    107. Autonomic nervous system reactivity: children with and without sickle cell disease. Nurs Res. 2011 May-Jun; 60(3):197-207. Treadwell MJ, Alkon A, Styles L, Boyce WT. PMID: 21532352; PMCID: PMC3130063.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    108. The mediating effects of family functioning on psychosocial outcomes in healthy siblings of children with sickle cell disease. Pediatr Blood Cancer. 2011 Dec 01; 57(6):1055-61. Gold JI, Treadwell M, Weissman L, Vichinsky E. PMID: 21360652.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    109. Transition from pediatric to adult care in sickle cell disease: establishing evidence-based practice and directions for research. Am J Hematol. 2011 Jan; 86(1):116-20. Treadwell M, Telfair J, Gibson RW, Johnson S, Osunkwo I. PMID: 21061308; PMCID: PMC5291694.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    110. Chart Card: feasibility of a tool for improving emergency department care in sickle cell disease. J Natl Med Assoc. 2010 Nov; 102(11):1017-23. Neumayr L, Pringle S, Giles S, Quirolo KC, Paulukonis S, Vichinsky EP, Treadwell MJ. PMID: 21141289; PMCID: PMC4950679.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    111. Education and employment status of children and adults with thalassemia in North America. Pediatr Blood Cancer. 2010 Oct; 55(4):678-83. Pakbaz Z, Treadwell M, Kim HY, Trachtenberg F, Parmar N, Kwiatkowski JL, Cunningham MJ, Martin M, Sweeters N, Neufeld EJ, Giardina PJ, Olivieri N, Yamashita RC, Vichinsky E. PMID: 20535817; PMCID: PMC2932798.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    112. A review of the literature on the multiple dimensions of chronic pain in adults with sickle cell disease. J Pain Symptom Manage. 2010 Sep; 40(3):416-35. Taylor LE, Stotts NA, Humphreys J, Treadwell MJ, Miaskowski C. PMID: 20656451; PMCID: PMC2989986.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    113. Stress reactivity as a moderator of family stress, physical and mental health, and functional impairment for children with sickle cell disease. J Dev Behav Pediatr. 2010 Jul-Aug; 31(6):491-7. Treadwell MJ, Alkon A, Quirolo KC, Boyce WT. PMID: 20585265; PMCID: PMC4593493.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    114. Psychosocial and behavioral outcomes in children with sickle cell disease and their healthy siblings. J Behav Med. 2008 Dec; 31(6):506-16. Gold JI, Mahrer NE, Treadwell M, Weissman L, Vichinsky E. PMID: 18784995.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    115. Detection and assessment of stroke in patients with sickle cell disease: neuropsychological functioning and magnetic resonance imaging. Pediatr Hematol Oncol. 2008 Jun; 25(5):409-21. Gold JI, Johnson CB, Treadwell MJ, Hans N, Vichinsky E. PMID: 18569843.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    116. An expanded Transactional Stress and Coping Model for siblings of children with sickle cell disease: family functioning and sibling coping, self-efficacy and perceived social support. Child Care Health Dev. 2008 Jul; 34(4):491-502. Gold JI, Treadwell M, Weissman L, Vichinsky E. PMID: 18485027.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    117. Quantification of analgesic use in children with sickle cell disease. Clin J Pain. 2007 Jan; 23(1):8-14. Jacob E, Miaskowski C, Savedra M, Beyer JE, Treadwell M, Styles L. PMID: 17277639.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    118. Sickle Cell Disease Health-Related Quality of Life Questionnaire Project. Blood. 2006 Nov 16; 108(11):3339-3339. Werner WE, Treadwell TM, Hassell HK, Keller KS, Levine LR. .
      View in: Publisher Site   Mentions:
    119. Using qualitative and quantitative strategies to evaluate knowledge and perceptions about sickle cell disease and sickle cell trait. J Natl Med Assoc. 2006 May; 98(5):704-10. Treadwell MJ, McClough L, Vichinsky E. PMID: 16749645; PMCID: PMC2569269.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    120. Changes in sleep, food intake, and activity levels during acute painful episodes in children with sickle cell disease. J Pediatr Nurs. 2006 Feb; 21(1):23-34. Jacob E, Miaskowski C, Savedra M, Beyer JE, Treadwell M, Styles L. PMID: 16428011.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    121. Autonomic reactivity and clinical severity in children with sickle cell disease. Clin Auton Res. 2005 Dec; 15(6):400-7. Pearson SR, Alkon A, Treadwell M, Wolff B, Quirolo K, Boyce WT. PMID: 16362543.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    122. Quality of Life (QOL) in Sickle Cell Disease (SCD). Blood. 2005 Nov 16; 106(11):1324-1324. Pakbaz PZ, Richards RL, Treadwell TM, Hackney-Stephens HE, Quirolo QK, Vichinsky VE. .
      View in: Publisher Site   Mentions:
    123. Barriers to adherence of deferoxamine usage in sickle cell disease. Pediatr Blood Cancer. 2005 May; 44(5):500-7. Treadwell MJ, Law AW, Sung J, Hackney-Stephens E, Quirolo K, Murray E, Glendenning GA, Vichinsky E. PMID: 15602707.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    124. Trends in complete blood count values during acute painful episodes in children with sickle cell disease. J Pediatr Oncol Nurs. 2005 May-Jun; 22(3):152-9. Jacob E, Miaskowski C, Savedra M, Beyer JE, Treadwell M, Styles L. PMID: 15855476.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    125. Are there phases to the vaso-occlusive painful episode in sickle cell disease? J Pain Symptom Manage. 2005 Apr; 29(4):392-400. Jacob E, Beyer JE, Miaskowski C, Savedra M, Treadwell M, Styles L. PMID: 15857743.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    126. A simple model to assess and improve adherence to iron chelation therapy with deferoxamine in patients with thalassemia. Ann N Y Acad Sci. 2005; 1054:486-91. Pakbaz Z, Fischer R, Treadwell M, Yamashita R, Fung EB, Calvelli L, Quirolo K, Foote D, Harmatz P, Vichinsky EP. PMID: 16339703.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    127. Quality of life in patients with thalassemia intermedia compared to thalassemia major. Ann N Y Acad Sci. 2005; 1054:457-61. Pakbaz Z, Treadwell M, Yamashita R, Quirolo K, Foote D, Quill L, Singer T, Vichinsky EP. PMID: 16339697.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    128. Barriers to Deferoxamine Adherence for Adults with Sickle Cell Disease. Blood. 2004 Nov 16; 104(11):3760-3760. Treadwell TM, Sung SJ, Murray ME, Hagar HR, Major MK, Hackney-Stephens HE, Glendenning GA, Hoehner HC, Vichinsky VE. .
      View in: Publisher Site   Mentions:
    129. Quality of Life in Patients with Thalassemia. Blood. 2004 Nov 16; 104(11):3786-3786. Pakbaz PZ, Treadwell TM, Yamashita2 YR, Foote FD, Vichinsky VE. .
      View in: Publisher Site   Mentions:
    130. Assessing Compliance to Iron Chelation Therapy in Patients with Thalassemia. Blood. 2004 Nov 16; 104(11):3787-3787. Pakbaz PZ, Fischer FR, Gamino GR, Quirolo QK, Yamashita YR, Treadwell TM, Fung FE, Harmatz HP, Vichinsky VE. .
      View in: Publisher Site   Mentions:
    131. Pain in children Are there phases to the vaso-occlusive episode in children with sickle cell disease. Journal of Pain. 2004 Apr 1; 5(3):s42. Jacob JE, Miaskowski MC, Savedra SM, Beyer BJ, Treadwell TM, Styles SL. .
      View in: Publisher Site   Mentions:
    132. Management of vaso-occlusive pain in children with sickle cell disease. J Pediatr Hematol Oncol. 2003 Apr; 25(4):307-11. Jacob E, Miaskowski C, Savedra M, Beyer JE, Treadwell M, Styles L. PMID: 12679645.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    133. Changes in intensity, location, and quality of vaso-occlusive pain in children with sickle cell disease. Pain. 2003 Mar; 102(1-2):187-93. Jacob E, Miaskowski C, Savedra M, Beyer JE, Treadwell M, Styles L. PMID: 12620610.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    134. Using quality improvement strategies to enhance pediatric pain assessment. Int J Qual Health Care. 2002 Feb; 14(1):39-47. Treadwell MJ, Franck LS, Vichinsky E. PMID: 11871628.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    135. Assessment of sickle cell pain in children and young adults using the adolescent pediatric pain tool. J Pain Symptom Manage. 2002 Feb; 23(2):114-20. Franck LS, Treadwell M, Jacob E, Vichinsky E. PMID: 11844631.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    136. Improving adherence with deferoxamine regimens for patients receiving chronic transfusion therapy. Semin Hematol. 2001 Jan; 38(1 Suppl 1):77-84. Treadwell MJ, Weissman L. PMID: 11206966.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    137. Improving adherence with deferoxamine regimens for patients receiving chronic transfusion therapy. Seminars in Hematology. 2001 Jan 1; 38(1, Suppl 1):77-84. Treadwell TM, Weissman WL. .
      View in: Publisher Site   Mentions:
    138. Comparing Children with Sickle Cell Disease and Their Healthy Siblings on Measures of Coping, Self-Efficacy, Social Support, and Behavioral Problems,. Journal of Developmental and Behavioral Pediatrics. 1999 Oct 1; 20(5):401. Gold GJ, Treadwell TM, Weissman WL, Vichinsky VE. .
      View in: Publisher Site   Mentions:
    139. Practice guidelines for the assessment of children with sickle cell pain. J Soc Pediatr Nurs. 1999 Apr-Jun; 4(2):61-73. Beyer JE, Platt AF, Kinney TR, Treadwell M. PMID: 10410355.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    140. Approaches to working with adult thalassemia patients in pediatric settings. Ann N Y Acad Sci. 1998 Jun 30; 850:516-7. Weissman L, Treadwell M, Foote D, Heer N, Vichinsky EP. PMID: 9668599.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    141. #652 Evaluation of home desferal care in transfusion dependent children with thalassemia and sickle cell disease (SCD). Journal of Pediatric Hematology/Oncology. 1996 Nov 1; 18(4):454. Weissman WL, Treadwell TM, Vichinsky VE. .
      View in: Publisher Site   Mentions:
    Marsha's Networks
    Concepts (309)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (26)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-9-g3adcefa5 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.